Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis associated with the use of immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System database.

HOME
>
論文・技術情報
>
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis associated with the use of immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System database.

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
Pubmed追加日	2025/7/3
投稿者	Pathak, Gaurav N; Desai, Amar D; Pathak, Anurag; Samie, Faramarz H
組織名	Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset,;NJ.;Department of Dermatology, Northwestern University, Chicago, IL.;Department of Computer Science, Rutgers University School of Arts and Sciences,;New Brunswick, NJ.;Department of Dermatology, Columbia University Irving Medical Center, New York,;NY. Electronic address: fs2614@cumc.columbia.edu.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40602530/